ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,966Medicare Part D Prescriptions Filled, Including Refills

Rank: 300 out of 1844

$498K Total Retail Price of All Prescriptions

Rank: 359 out of 1844

275 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 275 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,119 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 463 341 1 1
PRAVASTATIN SODIUM 360 300 2 10
OMEPRAZOLE 343 244 3 5
LISINOPRIL 321 283 4 4
FUROSEMIDE 286 264 5 7
SERTRALINE HCL 202 173 6 21
TRAMADOL HCL 175 140 7 18
METOPROLOL TARTRATE 168 136 8 11
GABAPENTIN 167 115 9 15
METFORMIN HCL 165 119 10 8
HYDROCODONE-ACETAMINOPHEN 164 80 S3 11 2
AMLODIPINE BESYLATE 144 135 12 6
SIMVASTATIN 143 116 13 3
ALLOPURINOL 140 125 14 29
CLONIDINE HCL 138 114 15 64
ZETIA 126 112 16 81
ATENOLOL 125 108 17 17
DONEPEZIL HCL 119 119 18 26
HYDROCHLOROTHIAZIDE 115 94 19 9
LANTUS 100 72 20 42
FLUOXETINE HCL 95 69 21 41
KLOR-CON M20 90 80 22 54
METOPROLOL SUCCINATE 87 87 23 14
ALBUTEROL SULFATE 85 85 24 115
WARFARIN SODIUM 85 84 24 13
EVISTA 79 76 26 95
MELOXICAM 78 60 27 28
PRENATAL PLUS 77 38 28 215
CITALOPRAM HBR 72 57 29 19
ADVAIR DISKUS 71 53 30 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 42 31 20
RANITIDINE HCL 69 59 32 38
CARVEDILOL 68 67 33 22
JANTOVEN 68 52 33 199
POTASSIUM CHLORIDE 66 58 35 16
DICLOFENAC SODIUM 66 41 35 122
SPIRIVA 66 52 35 57
POLYETHYLENE GLYCOL 3350 60 45 38 39
ALENDRONATE SODIUM 59 42 39 25
RISPERIDONE 58 49 40 65
CELEBREX 55 55 41 91
KLOR-CON M10 53 36 42 149
GLIMEPIRIDE 53 49 42 35
NAMENDA 52 52 44 33
ZOLPIDEM TARTRATE 52 33 44 23
OXYBUTYNIN CHLORIDE 51 36 46 103
ATORVASTATIN CALCIUM 51 49 46 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.